Cart
sales@molnova.com
sEH inhibitor-3
CAS No. 1809885-35-5
sEH inhibitor-3( —— )
Catalog No. M35641 CAS No. 1809885-35-5
sEH inhibitor-3 (compound 35) is a potent, orally active inhibitor of soluble epoxide hydrolase (sEH), acting on human sEH with a Ki of 0.75 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 686 | In Stock |
|
| 10MG | 938 | In Stock |
|
| 25MG | 1444 | In Stock |
|
| 50MG | 1841 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamesEH inhibitor-3
-
NoteResearch use only, not for human use.
-
Brief DescriptionsEH inhibitor-3 (compound 35) is a potent, orally active inhibitor of soluble epoxide hydrolase (sEH), acting on human sEH with a Ki of 0.75 nM.
-
DescriptionsEH inhibitor-3 (compound 35) is a potent and orally active soluble epoxide hydrolase (sEH) inhibitor with a Ki of 0.75 nM for human sEH.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorEpoxide Hydrolase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1809885-35-5
-
Formula Weight433.4
-
Molecular FormulaC19H23F4N3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=CC=C(OC(F)(F)F)C(F)=C1)NC2CCN(C(=O)C3CCOCC3)CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kin Sing Stephen Lee, et al. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain. Bioorg Med Chem. 2020 Nov 15;28(22):115735.?
molnova catalog
related products
-
PKG inhibitor peptid...
PKG inhibitor peptide TFA is an inhibitor of atp-competitive cGMP-dependent protein kinase (PKG), Ki 86 μM.
-
Droprenilamine
Droprenilamine (Valcor) is an alicyclic derivative of pentenylamine with antianginal properties.
-
Bruceantin
Bruceantin is a natural product isolated from Brucea antidysenterica. Bruceantin has antitumor activity against B16 melanoma, colon 38, and L1210 and P388 leukemia in mice.
